Treatment for Dry Cough Following Rhinosinusitis
For patients with a persistent dry cough following rhinosinusitis, a first-generation antihistamine/decongestant combination is the most effective first-line treatment, with intranasal corticosteroids as an important adjunct therapy. 1
Understanding Post-Rhinosinusitis Cough
Dry cough following rhinosinusitis is typically classified as a form of Upper Airway Cough Syndrome (UACS), previously known as postnasal drip syndrome. This cough persists after the initial infection has resolved due to:
- Ongoing upper airway inflammation
- Increased sensitivity of cough receptors
- Persistent mucus production
- Impaired mucociliary clearance
Treatment Algorithm
First-Line Treatment:
First-generation antihistamine/decongestant (A/D) combination
- Recommended regimen: Dexbrompheniramine maleate (6 mg twice daily) or azatadine maleate (1 mg twice daily) plus sustained-release pseudoephedrine sulfate (120 mg twice daily) 1
- Duration: Minimum 3 weeks 1
- Note: Begin with once-daily dosing at bedtime for a few days before increasing to twice daily to minimize sedation 1
Intranasal corticosteroids
Second-Line Options (if first-line treatment fails):
Inhaled ipratropium bromide
Nasal decongestants
- Short-term use only (maximum 5 days) 1
- Example: Oxymetazoline hydrochloride nasal spray
- Caution: Risk of rhinitis medicamentosa with prolonged use
For Severe or Persistent Cases:
Consider sinus imaging if no response to empiric A/D therapy 1
For confirmed chronic sinusitis:
For refractory cases:
Important Considerations
Medication Selection Tips:
- First-generation vs. newer antihistamines: First-generation antihistamines are more effective for non-allergic causes of UACS due to their anticholinergic properties 1
- Newer-generation antihistamines (loratadine, terfenadine) have been found ineffective for post-viral cough 1
Potential Side Effects:
- First-generation antihistamines: Sedation, dry mouth, urinary retention (especially in older men)
- Decongestants: Insomnia, jitteriness, tachycardia, hypertension, increased intraocular pressure
- Intranasal corticosteroids: Generally well-tolerated; epistaxis more common at higher doses 4
Duration of Treatment:
- Expect improvement within days to 2 weeks of initiating therapy 1
- Continue treatment for at least 3 weeks; intranasal corticosteroids should be continued for 3 months after cough resolution 1
Special Situations
For Environmental Triggers:
- Identify and avoid exposure to irritants
- Improve ventilation and consider air filters 1
For Rhinitis Medicamentosa:
- Discontinue offending nasal decongestant
- Consider weaning one nostril at a time 1
Monitoring and Follow-up
- Reassess after 2-4 weeks of treatment
- If no improvement, consider alternative diagnoses or additional imaging
- Consider referral if cough persists despite appropriate treatment
A targeted approach addressing the underlying post-rhinosinusitis inflammation with first-generation antihistamine/decongestant combinations and intranasal corticosteroids offers the best chance for resolution of dry cough following rhinosinusitis.